FDA.reportPublic FDA data

TAPENTADOL HYDROCHLORIDE

Substance profile for UNII 71204KII53, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for TAPENTADOL HYDROCHLORIDE
Structure render from PubChem CID 9838021

Substance Identity#

UNII
71204KII53
Preferred term
TAPENTADOL HYDROCHLORIDE
Registry number
175591-09-0
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C14H23NO.ClH
Chemical structure for TAPENTADOL HYDROCHLORIDE
Structure render from PubChem CID 9838021

Chemical And Database Identifiers#

InChIKey
ZELFLGGRLLOERW-YECZQDJWSA-N
SMILES
Cl.CC[C@H]([C@@H](C)CN(C)C)C1=CC=CC(O)=C1
RxCUI
857492
PubChem
9838021
NCIt
C68922
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound9838021pubchem.ncbi.nlm.nih.gov/compound/9838021
PubChem InChIKey SearchZELFLGGRLLOERW-YECZQDJWSA-Npubchem.ncbi.nlm.nih.gov/#query=ZELFLGGRLLOERW-YECZQDJWSA-N
RxNorm857492mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=857492
NCI ThesaurusC68922ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C68922
FDA Substance Registration System71204KII53precision.fda.gov/uniisearch/srs/unii/71204KII53

DailyMed Socrata Ingredients#

DailyMed label, SPL version table
DailyMed labelSPL version
These highlights do not include all the information needed to use NUCYNTA ® safely and effectively. See full prescribing information for NUCYNTA ® . NUCYNTA ® (tapentadol) immediate-release oral tablets C-II Initial U.S. Approval: 20081
These highlights do not include all the information needed to use NUCYNTA ® safely and effectively. See full prescribing information for NUCYNTA ® . NUCYNTA ® (tapentadol) immediate-release oral tablets C-II Initial U.S. Approval: 20081
These highlights do not include all the information needed to use NUCYNTA® safely and effectively. See full prescribing information for NUCYNTA®. NUCYNTA® (tapentadol) immediate-release oral tablets C-II Initial U.S. Approval: 20082
These highlights do not include all the information needed to use NUCYNTA™ safely and effectively. See full prescribing information for NUCYNTA™. NUCYNTA™ (tapentadol) immediate-release oral tablets C-II Initial U.S. Approval: 20082
NUCYNTA (TAPENTADOL HYDROCHLORIDE) TABLET, FILM COATED [LAKE ERIE MEDICAL SURGICAL & SUPPLY DBA QUALITY CARE PRODUCTS LLC]3049
NUCYNTA (TAPENTADOL HYDROCHLORIDE) TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
NUCYNTA (TAPENTADOL HYDROCHLORIDE) TABLET, FILM COATED [JANSSEN PHARMACEUTICALS, INC.]8
NUCYNTA ER (TAPENTADOL HYDROCHLORIDE) TABLET, FILM COATED, EXTENDED RELEASE [JANSSEN PHARMACEUTICALS, INC.]6
NUCYNTA (TAPENTADOL HYDROCHLORIDE) SOLUTION [JANSSEN PHARMACEUTICALS, INC.]4
NUCYNTA (TAPENTADOL HYDROCHLORIDE) TABLET, FILM COATED [BRYANT RANCH PREPACK]1
NUCYNTA (TAPENTADOL HYDROCHLORIDE) TABLET, FILM COATED [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]1
NUCYNTA ER (TAPENTADOL HYDROCHLORIDE) TABLET, FILM COATED, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]1
NUCYNTA ER (TAPENTADOL HYDROCHLORIDE) TABLET, FILM COATED, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]1